Association of anemia and cognitive dysfunction in patients with acute myelogenous leukemia and myelodysplastic syndrome

American Journal of Hematology

Volumn 86, Issue 11, 2011, Pages 950-952

  Wood, Susan M ^a   Meyers, Christina A ^a   Faderl, Stefan ^a   Kantarjian, Hagop M ^a   Pierce, Sherry A ^a   Garcia Manero, Guillermo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANEMIA; ARTICLE; ATTENTION; COGNITIVE DEFECT; DISEASE SEVERITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; MYELODYSPLASTIC SYNDROME; NEUROPSYCHOLOGICAL TEST; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; QUALITY OF LIFE; WORD RECOGNITION;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BIOLOGICAL MARKERS; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HEMOGLOBINS; HUMANS; INTELLIGENCE TESTS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROMES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 80054019715     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22151     Document Type: Article

References (13)

1. Cella D. The Functional Assessment of Cancer Therapy-anemia (FACT-An) scale: A new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 1997; 34: 9-13.
2. Jacobsen PB, Garland LL, Booth-Jones M, et al. Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy. J Pain Symptom Manage 2004; 28: 7-18.
3. Brown K, Esper P, Kelleher L, O'Neill J, Polovich M, White J. Chemotherapy and biotherapy guidelines and recommendations for practice. Pitssburgh, PA: Oncology Nursing Society, 2001.
4. Brown WS, Marsh JT, Wolcott D, et al. Cognitive function, mood and P3 latency: Effects of the amelioration of anemia in dialysis patients. Neuropsychologia 1991; 29: 35-45.
5. Meyers CA, Albitar M, Estey E. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 2005; 104: 788-793.
6. Cabeza R, Nyberg L. Imaging cognition II: An empirical review of 275 PET and fMRI studies. J Cogn Neurosci 2000; 12: 1-47.
7. Segalowitz SJ, Unsal A, Dywan J. CNV evidence for the distinctiveness of frontal and posterior enuroal processes in a traumatic brain-injured population. J Clin Exp Neuropsychol 1992; 14: 545-565.
8. Hast R, Hellstrom E. Therapeutic aspects of myelodysplastic syndromes in chronic phase. Leuk Red 1992; 16: 95-100.
9. Wechsler D. Wechsler Adult Intelligence Scale, 3rd ed. San Antonio: The Psychological Corporation, 1997.
10. Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins verbal learning test-revised: Normative data and analysis of inter-from and test-retest reliability. Clin Neuropsychol 1998; 12: 45-55.
11. Lezak MD, Howieson D, Loring D. Neuropsychological Assessment, 4th ed. New York: Oxford University Press, 2004.
12. Benton AL, Hamsher KD. Multilingual Aphasia Examination. Iowa City: AJA Associates, 1989.
13. Heaton RK, Grant I, Matthews CG. Comprehensive norms for an expanded Halstead-Reitan Battery: Demographic Correction, Research Findings, and Clinical Applications. Odessa, FL: Psychological Assessment Resources, 1991.